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Keratinocyte-speciﬁc Pten-null mice revealed distinct phenotypes, including epidermal and seba-
ceous gland hyperplasia. To determine the candidate genes that contribute to their phenotypes,
we analyzed a comprehensive gene expression of Pten-null keratinocytes using microarray technol-
ogy. Consequently, it was demonstrated that the most induced gene was adipocyte-speciﬁc fatty
acid-binding protein (FABP4). Collectively, it is conceivable that the FABP4 pathway mediates the
sebaceous gland hyperplasia in keratinocyte-speciﬁc Pten-null mice.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
PTEN (phosphatase and tensin homolog deleted from chromo-
some ten) is a tumor suppressor gene mutated in human sporadic
cancers such as glioblastoma, prostate and endometrial carcinoma
[1], and in several familial cancer predisposition syndromes,
including Cowden disease [2]. The tumor suppressor status of PTEN
relies on its normal cellular activity as a lipid phosphatase that
dephosphorylates the membrane phosphoinositides at the 3 posi-
tion of the inositol ring. This activity reduces the cellular levels
of second messenger phosphatidylinositol 3,4,5-trisphosphate
[PI(3,4,5)P3] and thus antagonizes the action of the phosphatidyl-
inositol 3-kinase (PI3K). PTEN inhibits a number of signaling path-
ways, including serine-threonine kinase Akt, as well as various
cellular processes, including proliferation, cell survival, and apop-
tosis [3].
We previously reported that keratinocyte-speciﬁc Pten-null
mice exhibit wrinkled skin because of epidermal hyperplasia and
hyperkeratosis, as well as rufﬂed, shaggy, and curly hair [4]. Histo-
logical examination revealed acanthosis, sebaceous gland hyper-
plasia and accelerated hair follicle morphogenesis. In this study,
we deﬁne genes and pathways that are dysregulated in Pten-nullchemical Societies. Published by E
ue-Narita).keratinocytes using microarray technology, which allows for global
expression proﬁling of large numbers of genes. Here we report the
possible contribution of adipocyte-speciﬁc fatty acid-binding pro-
tein (FABP4) to sebaceous gland hyperplasia in keratinocyte-spe-
ciﬁc Pten-null mice.
2. Materials and methods
2.1. Generation of mice bearing Pten-null kerationcytes
Ptenﬂox/ﬂox mice (129Ola  C57BL6/J F6), generated as previ-
ously described [5], were mated to K5Cre transgenic mice
(C57BL6/J background; [6]), in which expression of Cre is con-
trolled by the promoter of the keratinocyte-speciﬁc gene K5. Off-
spring carrying K5Cre and two copies of the ﬂoxed Pten allele
(K5CrePtenﬂox/ﬂox) and K5Cre plus two copies of the wild-type Pten
allele (K5CrePten+/+) were generated. All animal experiments were
approved by the Institutional Review Board of the Akita University
School of Medicine.
2.2. Microarray analysis
Keratinocyte cultures were established as described [4]. Total
RNA was prepared from cultured keratinocytes using RNeasy mini
RNA isolation kit (Qiagen, Valencia, CA, USA), and waslsevier B.V. All rights reserved.
1320 M. Tsuda et al. / FEBS Letters 583 (2009) 1319–1322reverse-transcribed, and ampliﬁed, using Bioarray High Yield RNA
Transcription Labeling Kit, (Enzo Biochem Inc., Farmingdale, NY).
Microarray analysis was performed according to the methods as
previously described [7,8]. Namely, 15 lg of labeled cRNA was
fragmented and hybridized to Murine Genome Array U74Av2 ar-
rays (Affymetrix, Santa Clara, CA), with the capacity to display
transcript levels of approximately 22000 human genes. Arrays
were washed, stained with anti-biotin streptavidin-phycoerythrin
labeled antibody and scanned using the Gene Array Scanner sys-
tem (Hewlett-Packard, Palo Alto, CA), and GeneChip 3.0 software
(Affymetrix) to determine the expression of each gene, as de-
scribed by Affymetrix. Intensity values from the chips were ob-
tained using Microarray Suite version 5.0 (Affymetrix), and scaled
by calculating the overall signal for each array to the arbitrary
number of 500. We used RNA from 2 groups of mice, 3 KO and 3
wild-type, 6 microarrays total. We deleted all genes not expressed
in our samples, i.e., marked as ‘‘Absent” from all samples by the
Affymetrix program, or expressed at levels less that 100 units. This
procedure yielded approximately 8200 expressed genes. Then, we
calculated the averages and standard deviations for the 8200 genes
in each experimental group. We converted the average expression
values into log2 form and calculated the fold changes. We consid-
ered as regulated those genes that had average expression differ-
ence between the two groups at least 1.5-fold, i.e., 0.58 on log2
scale.
2.3. RT-PCR
FABP4. was ampliﬁed from reverse-transcribed cDNA using
primers 50-TGGGAACCTGGAAGCTTGTCTC-30 (forward) and 50-
GCTGATGATCATGTTGGGCTTG-30 (reverse), expected product size
of 116 bp. Peroxisome proliferator-activated receptor gamma
(PPARc was ampliﬁed using primers 50-CCAGAGCATGGTG
CCTTCGCT-30 (forward) and 50-CAGCAACCATTGGGTGAGCTC-30 (re-
verse), expected product size of 241 bp. GAPDH was ampliﬁed
using primers 50-TGTGTCCGTCGTGGATCTGA-30 (forward) and 50-
TTGCTGTTGAAGTCGCAGGAG-30 (reverse), expected product size
of 150 bp. Transcripts were quantiﬁed with Thermal Cycler Dice
real time system (Takara Bio) with SYBR Premix EX Taq (Takara
Bio). Puriﬁed PCR amplicons were used to obtain absolute standard
curves.
2.4. Histological evaluation and immunohistochemistry
Dorsal skin samples were ﬁxed by bathing them in 4% PFA in
PBS (pH 7.4). Images of sebaceous glands in HE-stained sectionsWT KO
PPARγ
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Fig. 1. Histology (a,b), localization of PPARc (c,d) and areas of sebocytes (e) of keratinoc
that the sebaceous glands of the Pten-null mice (b,e) are hyperplastic relative to those
nucleus of sebocytes. Arrows indicate sebaceous glands. Bars 50 lm. *P < 0.01.were captured digitally (Olympus BH2 microscope and Nikon cool-
pix 880 camera). To measure the cell area of sebocytes, at least
three ﬁelds randomly chosen were analyzed in each section mea-
suring the area of 100 individual sebocytes using the Image J
software (a Java-based version of NIH image, http://rsb.info.nih.-
gov/ij/). For immunohistochemistry, parafﬁn-embedded samples
were de-parafﬁnized and subjected to heat-induced epitope retrie-
val using an autoclave pretreatment for 15 min at 121 C in 10 mM
citrate buffer. Then, the samples were pre-incubated with 0.3%
H2O2 in methanol for 30 min to block endogenous peroxidase
activity. The sections were incubated with rabbit polyclonal anti-
PPARc (1:50, H-100, Santa Cruz, overnight at 4 C), and were visu-
alized with plus Envision+ detection system-HRP (DAKO). As for
negative control, a preparation stained with normal goat serum
in place of the primary antibody was used.
3. Results
3.1. Gene expression proﬁling
In agreement with our previous results [4], histological evalua-
tion of HE-stained skin sections from K5CrePtenﬂox/ﬂox mice
showed sebaceous gland hyperplasia (Figs. 1a and b, and 2). This
prompted us to identify the genes that are responsible for their dis-
tinctive phenotypes using microarray technology. We found a total
151 (58 induced and 93 suppressed) genes whose expression dif-
fers between normal and Pten-null keratinocytes among the
8263 total genes expressed. Representative 20 genes with the
strongest induced or suppressed in Pten-null keratinocytes were
listed in Table 1.
The most strongly induced gene in Pten-null keratinocytes was
FABP4. This gene encodes a key mediator of intracellular transport
and metabolism of fatty acids in adipose tissues [9]. FABP4 binds
fatty acids with high afﬁnity and transports them to various com-
partments in the cell. Importantly, when in complex with fatty
acids, FABP4 interacts with and modulates the activity of PPARc
[10]. Because PPARc is reported to be required for the sebocyte dif-
ferentiation [10], the present results suggest that FABP4 plays a
role, at least in part, in the development of the sebaceous gland
hyperplasia in K5CrePtenﬂox/ﬂox mice.
We also identiﬁed a number of epidermal differentiation-related
genes located in 1q21 as differentially expressed. These, include
S100A8, S100A9, small proline-rich protein 2I (SPRR2I), small pro-
line-rich protein 2F (SPRR2F), and small proline rich-like 1
(SPRRL1). The complex containing, S100A8 and S100A9, also known
as Calgranulin A and B, is a major calcium- and zinc-binding protein40
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Fig. 2. RT-PCR analysis of FABP4 and PPARc expression in Pten-null and normal
keratinocytes. Note that FABP4 is up-regulated in Pten-null keratinocytes compared
with wild-type keratinocytes (a,b), and that PPARc is expressed equally in Pten-null
and control keratinocytes (a). *P < 0.05.
M. Tsuda et al. / FEBS Letters 583 (2009) 1319–1322 1321in the cytosol of keratinocytes [11]. Genes SPRR2I, SPRR2F, and
SPRRL1 encode a set of proteins that are cross-linked during epider-
mal differentiation and are integral components of the corniﬁed
envelope [12]. These results suggest that the altered expression of
genes located at 1q21 might be one of a key abnormality in acan-
thotic epidermis in K5CrePtenﬂox/ﬂox mice. We note that similar
gene expression patterns are reported in skin disorders such as pso-
riasis vulgaris [13].
Furthermore, we found that expression of the cytokine thymic
stromal lymphopoietin (Tslp) is strongly induced in keratinocytes
of Pten-null mice. Interestingly, TSLP was known to be highly ex-
pressed by epidermal keratinocytes from patients with atopic der-
matitis [14], and K14-TSLP transgenic mice overexpressing TSLP in
keratinocytes exhibit an atopic dermatitis like phenotype [15].
However, the skin of Pten-null mice did not show any allergic
inﬂammatory changes (data not shown), demonstrating that TSLP
does not act as a cytokine that lead to immunological events in
the Pten-null mice.
However, any PPAR target genes are not differentially ex-
pressed, thus suggesting that these genes may be regulated by
mechanisms other than up-regulation of mRNA levels.Table 1
Top 20 genes showing the greatest degree of change. Note that FABP4 and genes located
Symbol Genbank accession
nos.
Gene name
Induced genes
Fabp4 NM_024406 Fatty acid-binding protein 4, adipocyte
Tslp NM_021367 Thymic stromal lymphopoietin
S100a8 NM_013650 S100 calcium binding protein A8 (calgranulin A)
Sprr2i NM_011475 Small proline-rich protein 2I
S100a9 NM_009114 S100 calcium binding protein A9 (calgranulin B)
Gsta4 NM_010357 Glutathione S-transferase, alpha 4
Sprr2f NM_011472 Small proline-rich protein 2F
Sprrl1 NM_033175 Small proline rich-like 1
Suppressed genes
Ramp2 AA560093 Receptor(calcitonin)activity-modifying protein
Figf NM_010216 c-Fos induced growth factor
Orm1 BE628912 Orosomucoid1
Serpinb11 NM_025867 Serine (or cysteine) proteinase inhibitor, clade B (
Serpina12 AK014346 Serine (or cysteine) proteinase inhibitor, clade A (
antitrypsin), member 12
Krt1-23 NM_033373 Keratin complex 1, acidic, gene 23
Dnase1L2 BB114349 Deoxyribonuclease 1-like 2
Tgfa U65016 Transforming growth factor alpha
Sgk NM_019232 Serum/glucocorticoid regulated kinase
Igf2 NM_010514 Insulin-like growth factor 2
Il18rap NM_010553 Interleukin 18 receptor accessory protein
Sdc2 AI266824 Syndecan 23.2. Real-time (RT)-PCR and immunohistochemistry
To conﬁrm the changes in gene expression using an indepen-
dent assay, we analyzed FABP4 mRNA levels by RT-PCR. A strong
increase in the expression levels of FABP4 was detected Pten-null
keratinocytes (Fig. 2a), although a gel electrophoresis is not sensi-
tive enough to differentiate the fold change seen in other genes
(data not shown). The above ﬁnding was further validated with
quantitative RT-PCR showing that the expression level of FABP4
in Pten-null keratinocytes was higher than that of wild-type kerat-
inocytes (Fig. 2b). Results shown are from one trial representative
of three independent experiments.
Moreover, to explore the possible connection between the
activities of FABP4 and PPARc, we investigated the PPARc levels
of expression by immunohistochemistry and RT-PCR. In agreement
with previous reports [16], PPARc was localized exclusively in nu-
cleus of sebaceous glands in K5CrePten+/+ and K5CrePtenﬂox/ﬂox
mice (Fig. 1c and d). Similar levels of PPARc expression were
detected in Pten-null and normal keratinocytes (Fig. 2a), as were
observed in immortalized human facial sebocytes SZ95 cells [16].
4. Discussion
In this report, using K5CrePtenﬂox/ﬂox mice as a model of abnor-
mal epidermal differentiation, we analyzed a comprehensive gene
expression pattern that contributes to their phenotypes. The anal-
ysis identiﬁed induction of several epidermal differentiation-re-
lated genes at 1q21, which reﬂect on the hyperproliferative
conditions similar to psoriasis [13], Unexpectedly, microarray anal-
ysis also identiﬁed FABP4 as the most induced gene in Pten-null
keratinocytes. Consequently, our study sheds light on FABP4 as
playing an important role in the sebaceous differentiation. Inter-
estingly, cutaneous (or keratinocyte) FABP (FABP5), other isotype
of FABP, has been shown to be localized in sebaceous glands
[17], although the detailed mechanisms by which FABP5 contrib-
ute to sebaceous differentiation remained to be elucidated.
Recent studies suggest that FABP4 selectively enhances the
activities of PPARc, a member of the nuclear hormone receptor
family, that regulates genes involved in sebaceous differentiation
[18]. Moreover, PPARc-null cells cannot differentiate intoat 1q21 are induced in Pten-null keratinocytes.
Fold change
(KO/WT)
Biological process
5.32, Up Transport
3.14, Up Cytokine activity, extracellular
space
2.7, Up Calcium ion binding
2.6, Up Corniﬁed envelope
2.29, Up Calcium ion binding
2.01, Up Transferase activity
1.97, Up Corniﬁed envelope
1.89, Up Corniﬁed envelope
2.38, Down Transport
2.27, Down Vasculogenesis
2.22, Down Transport
ovalbumin), member 11 2.22, Down Protease inhibitor
alpha-1 antiproteinase, 2.08, Down Protease inhibitor
2.08, Down Intermediate ﬁlament
2.04, Down Apoptosis
2.0, Down Cell cycle, cell proliferation
1.96, Down Apoptosis
1.92, Down Proliferation, cell cycle
1.89, Down Receptor activity
1.85, Down Cytoskeletal protein binding
1322 M. Tsuda et al. / FEBS Letters 583 (2009) 1319–1322sebocytes in mice chimeric for PPARc [19]. Therefore, the involve-
ment of PPARc in sebaceous gland hyperplasia is a matter to be
elucidated in future studies. Furthermore, other important genes
seem to concern the role that the FABP4 signaling pathway plays
in the sebaceous differentiation. First, c-Myc blocked b-catenin-in-
duced ectopic hair follicle formation, whereas b-catenin blocked c-
Myc-induced sebaceous differentiation [20]. Second, sonic hedge-
hog promotes proliferation of progenitor cells of the hair lineage,
whereas Indian hedgehog stimulates proliferation of sebocyte pre-
cursors [21]. Third, disruption of b-catenin signaling by dominant
negative form of Lef1 triggers formation of both mouse [22] and
human [23] sebaceous tumors, as is the observation that hedgehog
signaling can trigger sebaceous gland hyperplasia [24]. Since we
are far from understanding the detailed interactions of FABP4
and genes described given above, further investigation is required
to verify the hypothesis put forward here.
While the present study opened a new avenue for understand-
ing the possible role of FABP4 in sebaceous differentiation, two
fundamental questions remain to be explored. First, does an exog-
enous synthetic PPARc agonist such as troglitazone modulate the
transcriptional activity of PPARc in PTEN-null keratinocytes? If this
is the case, does this cause the relocation of FABP4 from the cytosol
to the nucleus followed by induction of sebaceous differentiation-
related genes such as keratin 7/19 and epithelial membrane anti-
gen? Second, does any other isotype of FABP such as FABP5 con-
tribute to sebaceous differentiation in PTEN-null keratinocytes? If
this is the case, does FABP5 act in concert with any other isotype
of PPAR such as PPARa or PPARb/d with strict selectivities for both
ligands and receptor subtypes? Additional more comprehensive
experiments are ongoing to understand the complete scope of
the biological functions of FABPs in the epidermis and its
appendages.
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